We subsequently formulated a more certain probe, [18F]CFA, which was Employed in the current analyze To guage dCK exercise in tumors when handled with a little molecule dCK inhibitor. This probe can also be remaining researched inside of a clinical demo at our establishment to evaluate improvements in dCK activity pursuing cancer immunotherapy 18.